These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 1269191)

  • 21. Reversal of advanced digitoxin toxicity and modification of pharmacokinetics by specific antibodies and Fab fragments.
    Ochs HR; Smith TW
    J Clin Invest; 1977 Dec; 60(6):1303-13. PubMed ID: 914999
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Studies on metabolism and pharmacokinetics of alpha-acetyldigitoxin in man (author's transl)].
    Bodem G; Wirth K; Dengler HJ
    Arzneimittelforschung; 1975 Sep; 25(9):1448-52. PubMed ID: 1242671
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enhanced transformation of digitoxin to dihydrodigitoxin in humans with renal failure.
    Bodem G; Unruh EV
    J Clin Pharmacol; 1979 Apr; 19(4):195-9. PubMed ID: 438353
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Studies on digitalis. VIII. Digitoxin metabolism on a maintenance regimen and after a single dose.
    Storstein L
    Clin Pharmacol Ther; 1977 Feb; 21(2):125-40. PubMed ID: 837632
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Studies on digitalis. XII. Kinetic pattern of digitoxin metabolism in patients with biliary fistulas.
    Storstein L; Amlie J
    Clin Pharmacol Ther; 1977 Jun; 21(6):659-74. PubMed ID: 324692
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Some aspects of the distribution and disposition of digitoxin in man.
    Lukas DS
    Ann N Y Acad Sci; 1971 Jul; 179():338-61. PubMed ID: 5285380
    [No Abstract]   [Full Text] [Related]  

  • 27. Proceedings: The pharmakokinetics of 3H-digitoxin and its metabolites in the guinea-pig.
    Ingwersen F
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 282(Suppl):suppl 282:R38. PubMed ID: 4276569
    [No Abstract]   [Full Text] [Related]  

  • 28. Digitoxin accumulation.
    Ochs HR; Pabst J; Greenblatt DJ; Hartlapp J
    Br J Clin Pharmacol; 1982 Aug; 14(2):225-9. PubMed ID: 7104174
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative study of thin-layer chromatographic techniques for separation of digoxin, digitoxin and their main metabolites.
    Carvalhas ML; Figueira MA
    J Chromatogr; 1973 Nov; 86(1):254-60. PubMed ID: 4765314
    [No Abstract]   [Full Text] [Related]  

  • 30. Correlation between myocardial and plasma concentration of digitoxin and its metabolites with special reference to digitoxin radio-immunoassay.
    Hamamoto H; Takeda H; Katoh T; Tokuoka T; Kitamura K
    Jpn Circ J; 1976 Jul; 40(7):747-51. PubMed ID: 966363
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Kinetics of digitoxin and the bis- and monodigitoxosides of digitoxigenin in renal insufficiency.
    Graves PE; Fenster PE; MacFarland RT; Marcus FI; Perrier D
    Clin Pharmacol Ther; 1984 Nov; 36(5):607-12. PubMed ID: 6488681
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Elimination of tritiated gentamicin in normal human subjects and in patients with severely impaired renal function.
    Wilson TW; Mahon WA; Inaba T; Johnson GE; Kadar D
    Clin Pharmacol Ther; 1973; 14(5):815-22. PubMed ID: 4729899
    [No Abstract]   [Full Text] [Related]  

  • 33. The effects of activated charcoal on digoxin and digitoxin clearance.
    Park GD; Goldberg MJ; Spector R; Johnson GF; Feldman RD; Quee CK; Roberts P
    Drug Intell Clin Pharm; 1985 Dec; 19(12):937-41. PubMed ID: 4085353
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetics and disposition of the lipid-lowering drug acifran in normal subjects and in patients with renal failure.
    Cayen MN; Ferdinandi ES; Hicks DR; Gonzalez R; Cosyns L; Dubuc J; Kraml M; Edwards KD
    Clin Pharmacol Ther; 1990 Jan; 47(1):50-6. PubMed ID: 2295219
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of phenobarbital on digitoxin metabolism in guinea-pig liver slices.
    Cardoso MT; Carvalhas ML
    Xenobiotica; 1980 Oct; 10(10):779-84. PubMed ID: 7456493
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetics and bioavailability of digitoxin by a specific assay.
    MacFarland RT; Marcus FI; Fenster PE; Graves PE; Perrier D
    Eur J Clin Pharmacol; 1984; 27(1):85-9. PubMed ID: 6489430
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bioavailability and elimination of digitoxin in patients with hepatorenal insufficiency.
    Kirch W; Ohnhaus EE; Dylewicz P; Pabst J; Storstein L
    Am Heart J; 1986 Feb; 111(2):325-9. PubMed ID: 3946177
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [On the pharmacokinetics of peruvoside. II. Comparative studies with H3-ouabain and H3-digitoxin in guinea pigs].
    Garbe A; Nowak H
    Arzneimittelforschung; 1968 Dec; 18(12):1597-601. PubMed ID: 5756472
    [No Abstract]   [Full Text] [Related]  

  • 39. Studies on digitalis. II. The influence of impaired renal function on the renal excretion of digitoxin and its cardioactive metabolites.
    Storstein L
    Clin Pharmacol Ther; 1974 Jul; 16(1):25-34. PubMed ID: 4843236
    [No Abstract]   [Full Text] [Related]  

  • 40. Excretion of 3H-digitoxin and its metabolites following spironolactone pretreatment in rats.
    Castle MC; Lage GL
    Drug Metab Dispos; 1973; 1(3):590-7. PubMed ID: 4149454
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.